A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 974-979

  Shim, Se Hoon ^a   Hwangbo, Young ^a   Kwon, Young Joon ^a   Jeong, Hee Yeon ^a   Lee, Bun Hee ^b   Hwang, Jung A ^c   Kim, Yong Ku ^b,c  

^a Soonchunhyang University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Serotonin 1A receptor; TPH

Indexed keywords

CYTOSINE; GUANINE; SEROTONIN 1A RECEPTOR; THYMINE; TRYPTOPHAN HYDROXYLASE 2; TPH2 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENETIC PREDISPOSITION; GENETICS; NEUROPSYCHOLOGICAL TEST; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RISK;

ADOLESCENT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT1A; TRYPTOPHAN HYDROXYLASE;

EID: 77955051394     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.05.006     Document Type: Article

References (42)

1. Bellgrove M.A., Hawi Z., Kirley A., Gill M., Robertson I.H. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 2005, 43:1847-1857.
2. Bellgrove M.A., Hawi Z., Lowe N., Kirley A., Robertson I.H., Gill M. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet B Neuropsychiatr Genet 2005, 136B:81-86.
3. Benloucif S., Galloway M.P., Keegan M.J. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 1993, 265:373-377.
4. Biederman J., Faraone S.V., Keenan K., Knee D., Tsuang M.T. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990, 29:526-533.
5. Bottomley M.J., Collard M.W., Huggenvik J.I., Liu Z., Gibson T.J., Sattler M. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol 2001, 8:626-633.
6. Cadoret R.J., Stewart M.A. An adoption study of attention deficit/hyperactivity/aggression and their relationship to adult antisocial personality. Compr Psychiatry 1991, 32:73-82.
7. Castellanos F.X., Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002, 3:617-628.
8. Cho S.C., Kim J.W., Kim B.N., Hwang J.W., Park M., Kim S.A., et al. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample. Neuropsychobiology 2008, 57:131-138.
9. Czesak M., Lemonde S., Peterson E.A., Rogaeva A., Albert P.R. Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 2006, 26:1864-1871.
10. DuPaul G. ADHD rating scale. Attention-deficit hyperactivity disorder: a clinical workbook 1991, Guilford, New York. R.A. Barekley (Ed.).
11. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
12. Greenberg L.M., Waldman I.D. Developmental normative data on the test of variables of attention (TOVA). J Child Psychol Psychiatry 1993, 34:1019-1030.
13. Hong C.J., Chen T.J., Yu Y.W., Tsai S.J. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 2006, 6:27-33.
14. Iyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J Pharmacol Exp Ther 1996, 277:40-47.
15. Jacobsen K.X., Vanderluit J., Slack R.S., Albert P.R. HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression. Mol Cell Neurosci 2008, 38:349-358.
16. Kato M., Fukuda T., Wakeno M., Okugawa G., Takekita Y., Watanabe S., et al. Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 2009, 5(150B):115-123.
17. Kelland M.D., Chiodo L.A. Serotonergic modulation of midbrain dopamine systems. The Modulation of Dopaminergic Neurotransmission by Other Neurotransmitters 1996, 87-122. CRC Press, Inc., Boca Raton, FL. R. Charles, J. Ashby (Eds.).
18. Kim ST, Kim JH, Song DH, Lee HK, Chu YH, Hong CH, et al. The Manual of Korean Personality Inventory for Children(KPI-C). Seoul: Korea Guidance, 1997.
19. Kim J.Y., Ahn D.H., Shin Y.J. An epidemiological study of attention deficit, hyperactivity disorder and learning disabilities in a rural area. J Korean Neuropsychiatry Assoc 1999, 38:788-793.
20. Kim Y.S., Cheon K.A., Kim B.N., Chang S.A., Yoo H.J., Kim J.W., et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K- SADS-PL-K). Yonsei Med J 2004, 45:81-89.
21. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 1987, 329:75-79.
22. Le François B., Czesak M., Steubl D., Albert P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness rice. Neuropharmacology 2008, 55:977-985.
23. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003, 23:8788-8799.
24. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998, 44:151-162.
25. Mignon L., Wolf W.A. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat. Psychopharmacology(Berl) 2002, 163:85-94.
26. Mössner R., Walitza S., Geller F., Scherag A., Gutknecht L., Jacob C., et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 2006, 9:437-442.
27. Park K.S., Yoon J.Y., Park H.J., Won K.K. Korean Educational Development Institute-Wechsler Intelligence Scale for children 1991, Korean Educational Development Institute, Seoul.
28. Puig M.V., Celada P., Artigas F. Serotonergic control of prefrontal cortex. Rev Neurol 2004, 39:539-547.
29. Quist J.F., Barr C.L., Schachar R., Roberts W., Malone M., Tannock R., et al. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000, 5:537-541.
30. Quist J.F., Barr C.L., Schachar R., Roberts W., Malone M., Tannock R., et al. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol Psychiatry 2003, 8:98-102.
31. Retz W., Retz-Junginger P., Supprian T., Thome J., Rosler M. Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law 2004, 22:415-425.
32. Ribasés M., Ramos-Quiroga J.A., Hervás A., Bosch R., Bielsa A., Gastaminza X., et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 2009, 14:71-85.
33. Sheehan K., Lowe N., Kirley A., Mullins C., Fitzgerald M., Gill M., et al. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 2005, 10:944-949.
34. Sheehan K., Hawi Z., Gill M., Kent L. No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci Lett 2007, 412:105-107.
35. Shin M.S., Cho S., Chun S.Y., Hong K.E. A study of the development and standardization of ADHD diagnostic system. Korean J Child Adolesc Psychiatry 2000, 11:91-99.
36. Silberg J., Rutter M., Meyer J., Maes H., Hewitt J., Simonoff E., et al. Genetic and environmental influences on the covariation between hyperactivity and conduct disturbance in juvenile twins. J Child Psychol Psychiatry 1996, 37:803-816.
37. So Y.K., Noh J.S., Kim Y.S., Ko S.G., Koh Y.J. The reliability and validity of Korean Parent and Teacher ADHD Rating Scale. J Korean Neuropsychiatry Assoc 2002, 41:283-289.
38. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 1998, 39:65-99.
39. Tsuchida R., Kubo M., Shintani N., Abe M., Köves K., Uetsuki K., et al. Inhibitory effects of osemozotan, a serotonin 1A-receptor agonist, on methamphetamine-induced c-Fos expression in prefrontal cortical neurons. Biol Pharm Bull 2009, 32:728-731.
40. Wirt RD, Lachar D, Klinedinst JK, Seat PD. Multidimensional description of child personality: A Manual for the Personality Inverntory for children. Los Angeles, Western psychological Services, 1984.
41. Wu S., Comings D.E. A common C 1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 1999, 9:105-106.
42. Young K.A., Zavodny R., Hicks P.B. Effects of serotonergic agents on apomorphine induced locomotor activity. Psychopharmacology(Berl) 1993, 110:97-102.